Akero Therapeutics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Akero Therapeutics (AKRO) PT Raised to $75 at Jefferies
January 29, 2025 4:08 PM ESTJefferies analyst Michael Yee raised the price target on Akero Therapeutics (NASDAQ: AKRO) to $75.00 (from $50.00) while maintaining a Buy rating.
The analyst comments "We raise our PT to $75 based on $5-6B cap or $2-3B+ clear oppty in NASH based on strong F4... More
